Abstract
Pathophysiological models are urgently needed for personalized treatments of mental disorders. However, most potential neural markers for psychopathology are limited by low interpretability, prohibiting reverse inference from brain measures to clinical symptoms and traits. Neural signatures—i.e. multivariate brain-patterns trained to be both sensitive and specific to a construct of interest—might alleviate this problem, but are rarely applied to mental disorders. We tested whether previously developed neural signatures for negative affect and discrete emotions distinguish between healthy individuals and those with mental disorders characterized by emotion dysregulation, i.e. Borderline Personality Disorder (BPD) and complex Post-traumatic Stress Disorder (cPTSD). In three different fMRI studies, a total sample of 192 women (49 BPD, 62 cPTSD, 81 healthy controls) were shown pictures of scenes with negative or neutral content. Based on pathophysiological models, we hypothesized higher negative and lower positive reactivity of neural emotion signatures in participants with emotion dysregulation. The expression of neural signatures differed strongly between neutral and negative pictures (average Cohen’s d = 1.17). Nevertheless, a mega-analysis on individual participant data showed no differences in the reactivity of neural signatures between participants with and without emotion dysregulation. Confidence intervals ruled out even small effect sizes in the hypothesized direction and were further supported by Bayes factors. Overall, these results support the validity of neural signatures for emotional states during fMRI tasks, but raise important questions concerning their link to individual differences in emotion dysregulation.
Competing Interest Statement
C. Schmahl and C. Paret have served as consultants to Boehringer Ingelheim Pharma.
Clinical Trial
DRKS00000778, DRKS00005578
Funding Statement
Study 1 was funded by the German Research Foundation (grant no. SCHM 1526/8-2; HE2660/7-2). Study 2 was supported by the German Research Foundation (grant no. KFO 256, EN 361/13-2). Study 3 was financed by the German Ministry of Education and Research (BMBF) RELEASE 01KR1303A.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Board of the Medical Faculty Mannheim of the University of Heidelberg (Nr. 2010-243N-MA), Ethics Board of the Medical Faculty Mannheim of the University of Heidelberg (Nr. 2011-224N-MA), Ethical Board II of Heidelberg University (Nr.: 2013-635N-MA)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and annotated R scripts to reproduce the main analyses can be found on github. Demographic information used for sample description and fMRI images are not openly provided. Requests for primary data should be addressed directly to the corresponding author.
https://github.com/MaurizioSicorello/MVPAemoDys_Analyses.git
